Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05705804
NA

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Sponsor: Yonsei University

View on ClinicalTrials.gov

Summary

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2023-06-13

Completion Date

2027-06-01

Last Updated

2026-07-07

Healthy Volunteers

No

Interventions

DRUG

Pitavastatin

Pitavastatin 4 mg will be given.

DRUG

Pitavastatin plus Ezetemibe

Pitvastatin 4 mg plus ezetemibe 10 mg will be given.

DRUG

Atorvastatin

Atorvastatin 40 mg will be given.

Locations (1)

Yonsei University Health System, Severance Hospital

Seoul, South Korea